Global /Pakistan /Healthcare /Drug Manufacturers - General /BFBIO
chevron_leftBack
BF Biosciences Ltd. logo

BF Biosciences Ltd.

BFBIO
PSX: BFBIO Delayed
136.84PKR -3.3%
0.4918 USD
As of 5 June 2026, BF Biosciences Ltd. has a market cap of $42.42M USD, ranking #31745 globally and #157 in Pakistan. It ranks #2868 in the Healthcare sector, and #998 in the Drug Manufacturers - General industry.
Global Rank
31745
Country Rank
157
Sector Rank
2868
Industry Rank
998
Key Stats
Market Cap
$42.42MUSD
11.8B PKR
Enterprise Value
$45.4MUSD
12.63B PKR
Revenue (TTM)
$31.84MUSD
8.86B PKR
EBITDA (TTM)
$4.51MUSD
1.26B PKR
Net Income (TTM)
$2.13MUSD
591.76M PKR
EBITDA Margin
14%
Profit Margin
6.7%
PE Ratio
19.9
PS Ratio
1.3
PB Ratio
2.3
EV/EBITDA
10.1
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Muhammad Rafiq open_in_new
Employees
535
Founded
2006
Website
bfbio.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-3.3% -4.4% 3.4% -11% -7.9% 0.9%

News

Loading...

Markets

Exchange Ticker Price
Pakistan Stock Exchange
MIC: XKAR
PRIMARY
BFBIO
BF Biosciences Ltd
ISIN: PK0148201012
Shares Out.:
88.333M1 Shares Float: 25.0M2
TV:
SA:
YF:
GF:
BA:
MS:
136.84 PKR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About BF Biosciences Ltd.

BF Biosciences Limited, a biotech pharmaceutical company, manufactures, imports, and sells pharmaceutical products in Pakistan, Nepal, Afghanistan, Mauritania, Switzerland, and internationally. The company offers pharmaceutical products for various therapeutic areas, including cardiometabolic disorders, cardiology, diabetes, anti-obesity, hepatology, gastroenterology, chronic kidney diseases, dermatology, antifungal treatments, antibiotics, antivirals, rheumatoid arthritis, nephrology, and oncology. It also provides injectables in vials, ampoules, and pre-filled syringes forms. In addition, the company is involved in the sale of medical devices; and toll manufacturing services for pharmaceutical products to other pharmaceutical companies. It exports its products. The company was incorporated in 2006 and is headquartered in Lahore, Pakistan. BF Biosciences Limited is a subsidiary of Ferozsons Laboratories Limited.

Similar Companies

Industry: Drug Manufacturers - General (Pakistan)
Name
Market Cap diff.
PE
$399.67M
111.2B PKR
842%
11.1
$319.29M
88.83B PKR
653%
10.7
HALEON
$313.76M
87.29B PKR
640%
13.7
AGP
$182.87M
50.88B PKR
331%
13.6
$182.57M
50.79B PKR
330%
27.9
$179.05M
49.81B PKR
322%
12.1
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
2M%
38.1
JNJ
$547.28B
1M%
26.4
ABBV
$360.63B
850K%
97.4
$324.68B
256.25B CHF
765K%
19.9
AZN
$289.43B
215.59B GBP
682K%
27.6
NOVN
$277.35B
218.9B CHF
654K%
20.5
chevron_leftBack